Across TCGA pan-cancer cohorts, FUT1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated FUT1 data layer compared with 22 for mass-spec protein.
The strongest signal is observed in glioblastoma multiforme (GBM), where higher FUT1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FUT1 expression acts as an unfavorable survival marker.
GBM and SKCM are the cancer types where FUT1 Mutation most reproducibly stratifies survival.